Catch up on the top radiology content of the past week.
Commentary|Videos|January 22, 2026
What’s Coming Down the Pike in Radiology in 2026?
Author(s)Jeff Hall
In recent interviews, Rajesh Bhayana, M.D., Manisha Bahl, M.D., and Jeremie Calais, M.D., Ph.D., shared their thoughts on agentic AI, key directions in breast imaging research and emerging trends with prostate cancer theranostics in 2026.
Advertisement
Advertisement
What kind of impact will agentic AI have in 2026? Will we see new developments with risk-based screening in breast cancer research? Could we see the continued emergence of alpha-emitting theranostics for patients with prostate cancer?
Related to this article
Catch up on the top radiology content of the past week.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
Catch up on a variety of FDA news in radiology from the past week.
Advertisement
Advertisement